Newsroom
Sativex Receives Fast Track Status for Advanced Cancer Pain
Sativex,a cannabinoid developed together by GW Pharmaceuticals and Otsuka, receives FDA's Fast Track status for advanced cancer pain.
3D Printing Could Improve Drug Discovery and Development
3D printing of tumors could provide a more physiological environment to boost cancer drug discovery and development.
Healthcare Costs Among Young Adults Are About The Same, Whether They're Insured Or Not
Among surprises from a new study on U.S. health spending is the realization: Whether insured or not, young adults spent about the same on out-of-pocket health expenditures throughout the year.
Bonuses Still Tied to Better Financials
Quality-of-care performance means more to CEO paychecks at some for-profit hospital companies than at others.
Study: Costly Breast Cancer Treatment More Common At For-Profit Hospitals
Older breast cancer patients who received radiation treatment after surgery were more likely to undergo a more expensive and somewhat controversial type of radiation called brachytherapy if they got their care at for-profit rather than nonprofit hospitals, a new study reports.
PD-L1: Immunotherapy Response Biomarker in Lung Cancer?
PD-L1 protein levels could be an important biomarker to predict response to immunotherapy in NSCLC patients.
Phase III SYNERGY Trial: Disappointing Results in Metastatic CRPC
Teva Pharmaceutical Industries Ltd. and OncoGenex Pharmaceuticals, Inc. today announced results from the Phase III SYNERGY trial, a randomized, open-label, two-arm study comparing the combination of custirsen and standard first-line docetaxel/prednisone therapy to docetaxel/prednisone alone in men with metastatic castrate-resistant prostate cancer (CRPC)
ICD-10 Delay Derails More Than IT for Health Insurers
With the delay in ICD-10, many insurers now have to slow down a mammoth IT project and, potentially more disruptive, make adjustments to a whole slew of programs and contracts.
Could Managed Care Offset OK's Surge in Medicaid Spending for Emergency Room Visits?
Medicaid-financed emergency room costs statewide grew nearly $10 million to $178.3 million in fiscal year 2013.
ASTRO's New Guidelines on Post-operative Radiation Therapy for Endometrial Cancer
The American Society for Radiation Oncology (ASTRO) has issued a new guideline, The Role of Postoperative Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based Guideline, that details the use of adjuvant radiation therapy in the treatment of endometrial cancer. The guideline's executive summary is published in the May-June 2014 issue of Practical Radiation Oncology (PRO), the official clinical practice journal of ASTRO. The full-length guideline is available as an open-access article online.
Promising AML Treatment to Initiate Phase III Trial at Moffitt
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are showing better responses than patients treated with the standard drug formulation.
First Human HPV DNA Test for Cervical Cancer Screening Receives FDA Nod
The U.S. Food and Drug Administration today approved the first FDA-approved HPV DNA test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing for cervical cancer. The test also can provide information about the patient's risk for developing cervical cancer in the future.
Physician Payment Data is Where the Action Is
Look beyond the EHR incentive program. A national effort to turn CMS's recent release of Medicare physician payment data into useful, actionable data visualizations is the hottest HIT challenge right now.
The Changing World of Oncology Reimbursement, Are You Ready?
The expenses associated with cancer care in the United States are staggering and only expected to climb.
Chronic Prostate Inflammation May Increase Prostate Cancer Risk
Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer, according to researchers.
Bavituximab and Ipilimumab Combination Trial to be Initiated in Patients With Advanced Melanoma
Randomized trial to evaluate immune activation following treatment with immunotherapy combination. The open label design will allow for ongoing evaluation of clinical results from study.
Liquid Biopsy to Identify CTCs and Guide Treatment Decisions in Bladder Cancer
A blood test performed before radical cystectomy in patients with urothelial cancer of the bladder could identify the presence of circulating tumor cells (CTCs), which are predictive of outcome, according to a new study.
Fauci, Leading AIDS Researchers Discuss Vaccine Prospects in AJMC's Latest 'Evidence-Based' Title
Evidence-Based Immunology and Infectious Disease, the fourth title in the news series from The American Journal of Managed Care, launches with an issue that features interviews with leading AIDS researchers, a discussion of the challenges of paying for breakthrough therapies for hepatitis C, and new information on causes and treatments for rheumatoid arthritis.
Meet GenBank, the Tool that lets Scientists Unlock the Secrets Within the Data
What is the most important research tool in biology paid for by taxpayers that they don't know exists? It might be GenBank, the open-access database maintained by the National Institutes of Health, which allows scientists to dramatically reduce the time it takes to find druggable targets and identify genes in the evolution of personalized medicine.
ER Visits For Routine Dental Care Driving Up Hospital Costs
People who go to Michigan hospitals seeking treatment for dental conditions that could have been prevented through regular dental care increase health care costs by millions of dollars in the state.
CMS to Private Insurers: Adopt Payment Reforms More Quickly
Leaders from the Centers for Medicare & Medicaid Services think private insurers have been too slow to adopt payment reforms, but they would be best served by adopting value-based payment systems in tandem with CMS today.
FDA Advisory Committee Votes Against Moxduo Approval
- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Products Advisory Committee has voted to recommend against approval of Moxduo, an immediate release Dual Opioid® for the treatment of moderate to severe acute pain. The Advisory Committee found the Company did not provide sufficient evidence to warrant approval of Moxduo at this time.